These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab. Baheerathan A; McNamara C; Kalam S; Rane N; Barwick TD; Grote H; Nicholas R Neurology; 2018 Sep; 91(12):572-573. PubMed ID: 30224501 [No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy or immune reconstitution inflammatory syndrome after fingolimod cessation? A case report. Mickeviciene D; Baltusiene A; Afanasjeva B; Afanasjevas D; Gleizniene R; Rastenyte D; Berger JR BMC Neurol; 2022 Aug; 22(1):306. PubMed ID: 35986243 [TBL] [Abstract][Full Text] [Related]
10. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J; J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555 [TBL] [Abstract][Full Text] [Related]
11. PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy. Sierra Morales F; Illingworth C; Lin K; Rivera Agosto I; Powell C; Sloane JA; Koralnik IJ J Neurovirol; 2017 Oct; 23(5):789-792. PubMed ID: 28831749 [TBL] [Abstract][Full Text] [Related]
12. Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature. Augusto L; Neves N; Reis C; Abreu C; Sarmento A Acta Med Port; 2015; 28(3):286-96. PubMed ID: 26421780 [TBL] [Abstract][Full Text] [Related]
13. Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data. Sinnecker T; Hadisurya J; Schneider-Hohendorf T; Schwab N; Wrede K; Gembruch O; Gold R; Hellwig K; Pilgram-Pastor S; Adams O; Albrecht P; Hartung HP; Aktas O; Kraemer M BMC Neurol; 2019 Aug; 19(1):190. PubMed ID: 31399069 [TBL] [Abstract][Full Text] [Related]
14. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab. Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652 [TBL] [Abstract][Full Text] [Related]
16. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations. Soni N; Ora M; Mangla R; Singh R; Ellika S; Agarwal A; Meyers SP; Bathla G Mult Scler Relat Disord; 2023 Sep; 77():104830. PubMed ID: 37418930 [TBL] [Abstract][Full Text] [Related]
17. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170 [TBL] [Abstract][Full Text] [Related]